Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000478420 | SCV000570685 | likely pathogenic | not provided | 2017-12-07 | criteria provided, single submitter | clinical testing | A variant that is likely pathogenic has been identified in the SCN2A gene. The T435I variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The T435I variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In silico analysis predicts this variant is probably damaging to the protein structure/function. This substitution is predicted to be within the intracellular loop between the S6 transmembrane segment of the first homologous domain and the S1 transmembrane segment of the second homologous domain at a position where amino acids with similar properties to Threonine are tolerated across species. Additionally, targeted parental testing indicates this variant is apparently de novo in this individual. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |